The Future of GC/Q-TOF in Environmental Analysis

Abstract Gas chromatography/quadrupole time-of-flight mass spectrometry (GC/Q-TOF) offers high mass resolution and accurate mass data with the ability to perform structure elucidation and confirmation via MS/MS processes for a myriad of analytes in environmental and biological matrices. The ability of GC/Q-TOF to accurately measure persistent organic pollutants and deconvolve the data to identify and confirm new environmental contaminates in the same sample offers a powerful methodology for environmental analysis and the identification of exposure markers and disease biomarkers. In conjunction with environmental analysis, GC/Q-TOF can be used to explore the biologically relevant chemical space in an “omics” workflow and examine personal exposure to chemical entitles over time—a relatively new concept called the exposome, the measurement of which is called exposomics.

[1]  Stephen M Rappaport,et al.  Biomarkers intersect with the exposome , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[2]  Ryoiti Kiyama,et al.  Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. , 2004, Environmental health perspectives.

[3]  Ian A. Watson,et al.  Characteristic physical properties and structural fragments of marketed oral drugs. , 2004, Journal of medicinal chemistry.

[4]  David S. Wishart,et al.  T3DB: a comprehensively annotated database of common toxins and their targets , 2009, Nucleic Acids Res..

[5]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[6]  H. Mol,et al.  Full scan MS in comprehensive qualitative and quantitative residue analysis in food and feed matrices: How much resolving power is required? , 2009 .

[7]  Jean-Louis Reymond,et al.  Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry, Physicochemical Properties, Compound Classes, and Drug Discovery , 2007, J. Chem. Inf. Model..

[8]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[9]  Andrew Wilkinson Compendium of Chemical Terminology , 1997 .

[10]  Jean-Louis Reymond,et al.  Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 , 2012, J. Chem. Inf. Model..

[11]  C. Wild Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology , 2005, Cancer Epidemiology Biomarkers & Prevention.

[12]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[13]  Jean-Louis Reymond,et al.  Virtual exploration of the small-molecule chemical universe below 160 Daltons. , 2005, Angewandte Chemie.

[14]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[15]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.